A plethora of GLP-1 agonists: decisions about what to use and when
SL Samson, AJ Garber - Current diabetes reports, 2016 - Springer
Incretin-based therapies are important addition to our armamentarium for the treatment of
type 2 diabetes (T2DM). There are six Glucagon-like peptide-1 receptor agonists (GLP …
type 2 diabetes (T2DM). There are six Glucagon-like peptide-1 receptor agonists (GLP …
GLP-1 receptor agonists: a review of head-to-head clinical studies
JM Trujillo, W Nuffer, SL Ellis - Therapeutic advances in …, 2015 - journals.sagepub.com
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the
treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while …
treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while …
User's guide to mechanism of action and clinical use of GLP-1 receptor agonists
CF Shaefer Jr, P Kushner, R Aguilar - Postgraduate Medicine, 2015 - Taylor & Francis
Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are injectable
glucose-lowering medications approved for the treatment of adult patients with type 2 …
glucose-lowering medications approved for the treatment of adult patients with type 2 …
Comparison review of short-acting and long-acting glucagon-like peptide-1 receptor agonists
Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) are useful tools for
treating type 2 diabetes mellitus. In their recent position statement, the American Diabetes …
treating type 2 diabetes mellitus. In their recent position statement, the American Diabetes …
Glucagon-like peptide 1 receptor agonists for type 2 diabetes
D Hinnen - Diabetes spectrum, 2017 - Am Diabetes Assoc
The incretin system has become an important target in the treatment of type 2 diabetes in
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …
recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose …
Emerging GLP-1 receptor agonists
Introduction: Recently, glucagon-like peptide-1 receptor (GLP-1R) agonists have become
available for the treatment of type 2 diabetes. These agents exploit the physiological effects …
available for the treatment of type 2 diabetes. These agents exploit the physiological effects …
A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes
E Montanya - Expert opinion on pharmacotherapy, 2012 - Taylor & Francis
Introduction: Glucagon-like peptide-1 (GLP-1) receptor agonists are a valuable addition to
the type 2 diabetes armamentarium. They increase insulin secretion and reduce glucagon …
the type 2 diabetes armamentarium. They increase insulin secretion and reduce glucagon …
GLP-1 receptor agonists: practical considerations for clinical practice
C Triplitt, C Solis-Herrera - The Diabetes Educator, 2015 - journals.sagepub.com
Purpose Type 2 diabetes (T2D) imparts an increased risk of adverse health outcomes in
patients unable to achieve glycemic control. Patient education and individualization of …
patients unable to achieve glycemic control. Patient education and individualization of …
GLP-1 receptor agonists: an updated review of head-to-head clinical studies
JM Trujillo, W Nuffer, BA Smith - Therapeutic advances in …, 2021 - journals.sagepub.com
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the
treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while …
treatment of type 2 diabetes (T2D) because they effectively lower A1C and weight while …
GLP-1 receptor agonists: A review of glycemic benefits and beyond
LD Clark - JAAPA, 2024 - journals.lww.com
Type 2 diabetes mellitus (T2DM) is a chronic medical condition affecting millions of
individuals worldwide. The burden of disease is significant, as demonstrated by high …
individuals worldwide. The burden of disease is significant, as demonstrated by high …